Lorne Cross, MD

Addiction Treatment
How Will the App Approved by the FDA Help Fight Opioid Addiction?

How Will the App Approved by the FDA Help Fight Opioid Addiction?

Opioid addiction remains a disturbing problem in the United States. Many theories have been proposed and programs developed in the hopes of reducing the epidemic. The U.S. Food and Drug Administration recently approved a mobile app known as reSET-O, which is designed to enable opioid abusers to maintain sobriety as part of an outpatient treatment program.

 

Startling Statistics

During the first six months of 2017, more than 66,000 people became victims of drug overdoses that resulted in fatalities. In the same year, approximately 1.9 people suffered nonfatal overdoses after abusing opiates. The largest increase in the number of overdoses occurred in Delaware, New Jersey, Ohio, Pennsylvania and Washington D.C. It’s estimated that more than 20 million people in the United States are addicted to opioid medications.

 

ReSET-O

The app will be made available by prescription and provides cognitive behavior therapy online. Clients using the app will also receive transmucosal buprenorphine treatment. The therapy plan requires that clients must be 18 years of age or older. They must additionally stay under the direct supervision of a qualified medical practitioner.

 

After receiving the prescription, patients may then download the reSET-O app on a smartphone or other mobile device. The app provides users with a reward system in which clients earn icons from a prize wheel. The software additionally enables patients to report personal data that may include cravings, buprenorphine use and addiction triggers.

 

Dr. Corey McCann, the CEO and president of Pear Therapeutics, explains that given the current addiction statistics, new therapies are needed to address the problem. The FDA-approved app provides a new method of helping opioid abusers deal with their addiction when used in combination with medication.

 

The Results

The reSET-O was approved via the 501(k) pathway. The program enables companies to gain approval of a device that is demonstrated as being similar to previous versions. The FDA approved the app following data submitted from a 12-week trial involving 170 volunteers. Half of the group were prescribed buprenorphine in combination with the reSET-O app. The control group received the medication alone. All participated in the study while under the direct supervision of clinicians. They also submitted to three urine samples each week. Following the 12 weeks, 82.4 percent of the reSET-O group maintained sobriety compared to 68.4 percent in the control group.

About Lorne Cross

Lorne Cross, MD is a healthcare professional from Portland, Oregon, who specializes in Addiction Medicine. It’s no secret that the United States is facing an opioid crisis. There are more lives lost to overdose deaths each year than were lost in the entire Vietnam War, and new data shows that opioids now kill more people each year than breast cancer. Understanding and treating the opioid crisis is of utmost importance to this country, and Dr. Cross has chosen to specialize in Addiction Medicine and focus all of his professional attention on this critical problem.

As the Medical Director of the Willamette Valley Treatment Center, Dr. Cross is the leader of a team that provides Medication Assisted Treatment to patients with Opioid Use Disorder. Lorne Cross, MD also serves as the Medical Director of a new Opioid Treatment Program in the Yamhill County Jail. Focusing on the treatment of opiate addiction, rather than punishment, can help to prevent relapse, decrease the rate of overdose deaths, and help to lower recidivism in the jail population, putting inmates on the right path upon release. Giving patients a path to recovery ultimately sets them up for more success in their futures.

Dr. Cross is hopeful as he looks into the future of treatment opportunities for opiate addiction. He sees the expansion of treatment into jails and prisons as a necessary step towards treating the opioid crisis and preventing unnecessary overdose deaths. Treating addiction with a rehabilitative approach is one of the best ways to reach out to those who truly need it most.

  • Senior Medical School Class Officer
  • Scholastic Honors Program Graduate
  • John Philip Sousa Award 1988

Years' Experience in Healthcare

Years Serving as a Major in the U.S. Army Reserve

Published Research Articles

From the time he was a child, Lorne Cross, MD was always fascinated by medicine and the natural sciences. By the time he reached college he knew he wanted to attend medical school and pursue his medical degree. He graduated in the top third of his class from Loma Linda University School of Medicine and completed his medicine internship and his anesthesiology residency at Loma Linda University Medical Center. Loma Linda University is a coeducational health sciences university located in California. He is also a Magna Cum Laude graduate of the Scholastic Honors Program at Southwestern Adventist College, where he earned his Bachelor of Science in Biology. Southwestern Adventist College is a small college, with an undergraduate enrollment of around 800 students, located in Texas.

Outside of work, Lorne Cross, MD likes to maintain an active and healthy lifestyle. He is an avid cyclist and bicycle racer, while actively pursuing many other sports. Outside of spending time exercising, he also loves to travel to new locations and spend time with his two teenage children and family.